O
OATS
Botanical Name: | Avena sativa |
Family: | Gramineae |
Plant Parts Used: | Oats seed:mature seed Green oats:aerial parts, including seed at the immature, milky stage |
PRESCRIBING INFORMATION
Actions | Oats seed:nervine tonic, tonic, thymoleptic | |
Green oats:nervine tonic, anxiolytic | ||
Potential Indications | Based on appropriate evaluation of the patient, practitioners should consider prescribing oats seed in formulations in the context of: | |
Based on appropriate evaluation of the patient, practitioners should consider prescribing green oats in formulations in the context of: | ||
Contraindications | None known. | |
Warnings and Precautions | None required. | |
Interactions | None known. | |
Use in Pregnancy and Lactation | No adverse effects expected. | |
Side Effects | None expected if taken within the recommended dose range. | |
Dosage | Oats seed: | |
Dose per day* | Dose per week* | |
3-6 ml of 1:1 liquid extract | 20-40 ml of 1:1 liquid extract | |
Green oats: | ||
Dose per day** | Dose per week** | |
3-6 ml of 1:2 liquid extract | 20-40 ml of 1:2 liquid extract |
* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.
** This dose range is extrapolated from King’s American Dispensatory 1983 and the author’s education and experience.
SUPPORTING INFORMATION
1 British Herbal Medicine Association’s Scientific Committee. British herbal pharmacopoeia. Bournemouth: BHMA, 1983.
2 Felter HW, Lloyd JU. King’s American dispensatory, ed 18. Portland: Eclectic Medical Publications, 1905. rev 3, reprinted 1983
3 Vogel A. The nature doctor. Teufen, Switzerland: Verlag A. Vogel, 1977.
4 Connor J, et al. J Pharm Pharmac. 1975;27(2):92-98.
5 Juzwiak S, et al. Herba Polonica. 1994;40(1-2):50-58.
6 Jack RA. Br Med J. 1971;4(778):48.
7 Anand CL. Nature. 1971;233(5320):496.
8 Geckeler K, Schmidt K, Schmidt F. Munch Med Wochenschr. 1974;116(11):581-582.
9 Gabrynowicz JW. Med J Aust. 1974;2(8):306-307.
10 Netherlands Patent 7412625, 1976.
11 Schmidt K, Geckeler K. Int J Clin Pharmacol. 1976;14(3):214-216.
12 Bye C, et al. Nature. 1974;252(5484):580-581.
OLIVE LEAF
Botanical Name: | Olea europaea |
Family: | Oleaceae |
Plant Part Used: | Leaf |
PRESCRIBING INFORMATION
Actions | Hypotensive, antioxidant, bitter tonic | |
Potential Indications | Based on appropriate evaluation of the patient, practitioners should consider prescribing olive leaf in formulations in the context of: | |
The much-publicized clinical antibacterial and antiviral activities of olive leaf are not supported by a rational analysis of the pharmacologic data. Even if any clinical improvement in infected patients after using olive leaf was definitely established by controlled clinical trials, this would not be proof of antimicrobial activity because other mechanisms of action (such as immune-enhancing activity) might apply. | ||
Contraindications | None known. | |
Warnings and Precautions | None required. | |
Interactions | None known. | |
Use in Pregnancy and Lactation | No adverse effects expected. | |
Side Effects | Traditional sources indicate that olive leaf may cause gastric upset, thus it should be taken before meals.1 | |
Dosage | Dose per day* | Dose per week* |
3.5-7.0 ml of 1:2 liquid extract | 25-50 ml of 1:2 liquid extract |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

